Europe moves to combat emerging diseases threat
MORE funding into research to combat unexpected new epidemic threats has been pledged by the European Commission.
An additional 12 million euros ($16.48 million) from the European Union Research Framework Programme will reinforce Europe’s capacity to deal with new disease strains such as the E. coli strain that recently infected 4000 people in Europe and caused 46 deaths.
A consortium, called ANTIGONE (Anticipating the Global Onset of Novel Epidemics) will begin research on the new strain, as well as other virulent pathogens.
The 14 partners from seven countries will build knowledge and resources to identify, study and prevent human health threats.
These include Shiga toxin-producing E. coli (STEC), Crimean-Congo haemorrhagic fever (CCHF), Ebola, and severe acute respiratory syndrome (SARS).